Novavax’s COVID-19 vaccine shown to be nearly 90% effective in UK clinical trial; immunity against new variants mixed. The findings showed the vaccine also provided strong immunity against the UK variant, but another interim study found limited effectiveness against the variant from South Africa. Ref. USAToday.
Novavax vaccine over 90% effective against COVID-19, study shows. The vaccine is more than 90% effective in protecting against infection and even more protective against some of the variants, Novavax said Monday. The company expects to request federal authorization for its vaccine this summer after it completes final chemistry, manufacturing, and control requirements. Ref. USAToday.